{"id":192511,"name":"CONTINUING MEDICAL EDUCATION COALITION","slug":"continuing-medical-education-coalition","state":"DC","description":null,"totalSpending":1740000,"filings":30,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":200000},{"year":2021,"income":150000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":210000},{"year":2025,"income":380000}],"firms":["THORN RUN PARTNERS"],"lobbyists":["WILLIAM LAMOND","ANDREW ROSENBERG","GARY PALMQUIST","JESSIE BRAIRTON","MICHAEL MCCARTHY"],"issues":["MED","HCR",null],"sampleDescriptions":["Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.\nIssues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS.","Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.\nIssues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS;\nSUPPORT for Patients and Communities Act (H.R.6); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).","Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.\nIssues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS;\nSUPPORT for Patients and Communities Act (H.R.6/P.L.115-271); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).","Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.\nIssues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS;\nExpressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8).","Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.\nIssues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS;\nExpressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8).\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.","Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.\nExpressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8).\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.","Issues related to the promotion of continuing medical education (CME) and the pandemic.\nH.R. 748 and S. 3548, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.","Issues related to the promotion of continuing medical education (CME) and the pandemic.\nThe Cares Act, Public Law 116-136.\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars. \nH.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021.\nH.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.\nSenate COVID-19 response legislation.","Issues related to the promotion of continuing medical education (CME) and the pandemic.\nThe Cares Act (P.L. 116-136).\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.\nH.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021.\nH.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.\nSenate COVID-19 response legislation.","Issues related to the promotion of continuing medical education (CME) and the pandemic.\nH.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021.\nHR 133, Consolidating Appropriations Act, 2021.","Issues related to the role of continuing medical education (CME).\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.","Issues related to the role of continuing medical education (CME).\nPolicies to promote the use of continuing medical education to support greater physician understanding about biosimilars.\nIssues related to COVID-19 related CME.\nS. 201, Improving Access to Health Care in Rural and Underserved Areas Act.\nH.R. 19, Lower Costs, More Cures Act of 2021.\nS. 2235, MATE Act of 2021.\nS. 987, CARA 3.0 Act of 2021","S. 201, The Improving Access to Health Care in Rural and Underserved Areas Act.\nH.R. 19, Lower Costs, More Cures Act of 2021.\nH.R. 2067/S. 235, Medication Access and Training Expansion (MATE) Act of 2021.\nH.R. 4341/S. 987, Comprehensive Addiction and Recovery Act (CARA) 3.0 Act of 2021.","Issues related to the role of continuing medical education (CME). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars. Issues related to COVID-19 related CME.","S. 201, The Improving Access to Health Care in Rural and Underserved Areas Act. H.R. 19, Lower Costs, More Cures Act of 2021. H.R. 2067/S. 235, Medication Access and Training Expansion (MATE) Act of 2021. H.R. 4341/S. 987, Comprehensive Addiction and Recovery Act (CARA) 3.0 Act of 2021.","Issues related to the role of continuing medical education (CME). Issues related to COVID-19 related CME.","Issues related to COVID-19 and the role of provider education in public health.","Issues related to rural health education and the role of provider education in public health.","Issues related to provision of continuing medical education."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}